Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast

Journal of the National Cancer Institute - Monographs

Volumn 41, Issue , 2010, Pages 162-177

  Davidson, N ^a   Gelber, R ^a   Piccart, M ^a,o   Pruneri, G ^a   Pritchard, K ^a   Ravdin, P ^a   Robertson, J ^a   Swain, S ^a   Abe, O ^b,cs   Enomoto, K ^b   Kikuchi, K ^b,cs   Masuda, H ^b   Nomura, Y ^b,df   Ohashi, Y ^b   Sugimachi, K ^b   Toi, M ^b   Tominaga, T ^b   Uchino, J ^b   Yoshida, M ^b   Haybittle, J L ^c   Leonard, C F ^d   Calais, G ^e   Geraud, P ^e   Collett, V ^f   Davies, C ^f,al   Delmestri, A ^f,al   Sayer, J ^f,al   Holdaway, T M ^g   Mason, B H ^g   Forbes, J F ^h,fb   Bauernhofer, T ⁱ   Dubsky, P ⁱ   Fesl, C ⁱ   Fohler, H ⁱ   Filipcic, L ⁱ   Fridrik, M ⁱ   Gnant, M ⁱ   Greil, R ⁱ   Hegenbarth, K ⁱ   Jakesz, R ⁱ   Kwasny, W ⁱ   Lang, A ⁱ   Luschin Ebengreuth, G ⁱ   Marth, C ⁱ   Menzel, C ⁱ   Mlineritsch, B ⁱ   Samonigg, H ⁱ   Seifert, M ^i,fi   Sevelda, P ^i,fi   Singer, C ⁱ   Steger, G G ⁱ   Stoger H ⁱ   Thaler, J ⁱ   Tschmelitsch, J ⁱ   Zielinski, C ^i,fi   Focan, C ^k   Peek, U ^l   Oates, G D ^m   Powell, J ^m   Durand, M ⁿ   Mauriac, L ⁿ   Di Leo, A ^o   Masood, M B ^p   Parker, D ^p   Price, J J ^p   Lindsay, M A ^q   Mackey, J ^q   Martin, M ^q,bp   Hupperets, P S G J ^r   Bates, T ^s   Blamey, R W ^s,dp   Chetty, U ^s,au   Ellis, I O ^s,fb   Mallon, E ^s   Morgan, D A L ^s,dp   Patnick, J ^s   Jackson, S ^t   Ragaz, J ^t   Berry, D ^u   Cirrincione, C ^u   Norton, L ^u,cz   Abu Zahra, H T ^v   Portnoj, S M ^w   Cuzick, J ^x,fb   Dowsett, M ^x   Houghton, J ^x   Ledermann, J ^x   Riley, D ^x   Bowdon, S ^x   Brookes, C ^x   Fernando, I ^x   Rea, D ^x,fk   Spooner, D ^x,fk   Gordon, N H ^z   Davis, H L ^aa   Lehingue, Y ^ab   Dubois, J B ^ac   Griffon, B ^ad   Mace Lesec'h J ^ad   Rambert, P ^ae   Mustacchi, G ^af   Petruzelka, L ^ag   Pribylova, O ^ag   Owen, J R ^ah   Harbeck, N ^ai   Meisner, C ^ai   Thomssen, C ^ai   Meier, P ^aj   Howell, A ^ak   Swindell, R ^ak,dl   Burrett, J ^al   Clarke, M ^al   Collins, R ^al   Correa, C ^al   Cutter, D ^al   Darby, S ^al   Davies, K ^al   Elphinstone, P ^al   Evans, V ^al   Gettins, L ^al   Godwin, J ^al   Gray, R ^al,at   Gregory, C ^al   Hermans, D ^al   Hicks, C ^al   James, S ^al   Kerr, A ^al   MacKinnon, E ^al   McGale, P ^al   McHugh, T ^al   Taylor, C ^al   Wang, Y ^al   De Oliveira, C F ^am   Gervasio H ^am   Johansen, H ^an   Mouridsen, H T ^an,ap   Gelman, R S ^ao   Harris, J R ^ao   Hayes, D ^ao,en   Henderson, I C ^ao   Winer, E ^ao   Christiansen, P ^ap   Ejlertsen, B ^ap   Ewertz, M ^ap   Moller S ^ap   Overgaard, M ^ap   Carstensen, B ^aq   Palshof, T ^aq   Dalesio, O ^as   De Vries, E G E ^as   Van Tinteren, H ^as   Davidson, N E ^at   Sledge, G ^at   Solin, L J ^at   Tormey, D C ^at   Wood, W ^at   Cameron, D ^au   Forrest, P ^au   Rossbach, J ^av   Klijn, J G M ^aw   Treurniet Donker, A D ^aw   Costa, A ^ax,bb   Veronesi, U ^ax   Viale, G ^ax   Bartelink, H ^ay   Bogaerts, J ^ay   Bijker, N ^ay,fp   Julien, J P ^ay   Legrand, C ^ay   Rutgers, E ^ay   Sylvester, R ^ay   Van De Velde, C J H ^ay   Van Nes, J G H ^ay   Cunningham, M P ^az   Huovinen, R ^ba   Joensuu, H ^ba   Tinterri, C ^bb   Valagussa, P ^bb,bc,co   Goldstein, L J ^bd   Bonneterre, J ^be   Fargeot, P ^be   Fumoleau, P ^be   Kerbrat, P ^be   Luporsi, E ^be   Namer, M ^be   Eiermann, W ^bf   Hilfrich, J ^bf   Jonat, W ^bf   Kaufmann, M ^bf,bt   Kreienberg, R ^bf   Schumacher, M ^bf,bg   Rauschecker, H ^bg   Sauer, R ^bg   Sauerbrei, W ^bg   Schauer, A ^bg   Blohmer, J U ^bh   Eidtmann, H ^bh   Gerber, B ^bh   Jackisch, C ^bh   Loibl, S ^bh   Von Minckwitz, G ^bh   De Schryver, A ^bi   Vakaet, L ^bi   Belfiglio, M ^bj   Nicolucci, A ^bj   Pellegrini, F ^bj   Sacco, M ^bj   Smith, D C ^bk   Stallard, S ^bk   Galligioni, E ^bl   Lopez, M ^bm   Boccardo, F ^bn   Rubagotti, A ^bn   Dent, D M ^bo   Gudgeon, C A ^bo   Hacking, A ^bo,eg   Murray, E ^bo   Panieri, E ^bo   Carrasco, E ^bp   Erazo, A ^bq   Horiguchi, J ^br   Takei, H ^br   Fentiman, I S ^bs,fb   Hayward, J L ^bs   Rubens, R D ^bs   Skilton, D ^bs   Scheurlen, H ^bt   Sohn, H C ^bt   Untch, M ^bu,cm   Dafni, U ^bv,bw   Markopoulos, C ^bv   Fountzilas, G ^bw   Mavroudis, D ^bx   Klefstrom, P ^by   Blomqvist, C ^bz   Saarto, T ^bz   Gallen, M ^ca   Margreiter, R ^cb   De Lafontan, B ^cc   Mihura, J ^cc   Roche H ^cc,dv,eu   Asselain, B ^cd   Salmon, R J ^cd   Vilcoq, J R ^cd   Arriagada, R ^ce   Hill, C ^ce   Laplanche, A ^ce   Le M G ^ce   Spielmann, M ^ce   A'Hern R ^cf,eb   Bliss, J ^cf   Ellis, P ^cf   Kilburn, L ^cf   Yarnold, J R ^cf,eb   Bruzzi, P ^cg   Del Mastro, L ^cg,dk   Pronzato, P ^cg   Sertoli, M R ^cg   Venturini, M ^cg,dk   Benraadt, J ^ci   Kooi, M ^ci   Van de Velde, A O ^ci   Van Dongen, J A ^ci   Vermorken, J B ^ci   Castiglione, M ^cj,eq,er   Collins, J ^cj   Forbes, J ^cj   Gelber, R D ^cj   Goldhirsch, A ^cj,eq,er   Lindtner, J ^cj   Price, K N ^cj   Raina, V ^cj   Rudenstam, C M ^cj   Senn, H J ^cj,eq,er   Bliss, J M ^ck   Chilvers, C E D ^ck   Marty, M ^ck   Buyse, M ^cl   Possinger, K ^cm   Schmid, P ^cm   Wallwiener, D ^cm   Borovik, R ^cn   Brufman, G ^cn   Hayat, H ^cn   Robinson, E ^cn   Bonadonna, G ^co   Camerini, T ^co   De Palo, G ^co   Di Mauro, M G ^co   Formelli, F ^co   Martoni, A ^cp   Cocconi, G ^cq,dw   Camisa, R ^cq   Gori, S ^cq   Aogi, K ^cr   Ikeda, T ^cs   Inokuchi, K ^cs   Sawa, K ^cs,dt   Sonoo, H ^ct   Korzeniowski, S ^cu   Skolyszewski, J ^cu   Ogawa, M ^cv   Christiaens, R ^cw   Paridaens, R ^cw   Van Den Bogaert, W ^cw   Braun, S ^cx   Janni, W ^cx   Martin, P ^cy   Hudis, C A ^cz   Wittes, R ^cz   Giokas, G ^da   Kondylis, D ^da   Lissaios, B ^da   Altemus, R ^dc   Camphausen, K ^dc   Cowan, K ^dc   Danforth, D ^dc   Lichter, A ^dc   Lippman, M ^dc   O'Shaughnessy J ^dc   Pierce, L J ^dc   Steinberg, S ^dc   Venzon, D ^dc   Zujewski, J A ^dc   D'Amico C ^dd   Lioce, M ^dd   Paradiso, A ^dd   Chapman, J W ^de   Goss, P E ^de   Levine, M N ^de   Myles, J D ^de   Pater, J L ^de   Pritchard, K I ^de,dr,ew,ex   Shepherd, L E ^de   Tu, D ^de   Whelan, T ^de,dr   Anderson, S ^dg   Bass, G ^dg   Brown, A ^dg   Bryant, J ^dg   Costantino, J ^dg   Fisher, B ^dg   Geyer, C ^dg   Redmond, C ^dg   Wickerham, L ^dg   Wolmark, N ^dg   Jackson, I M ^dh   Palmer, M K ^dh   Perez, E ^di   Ingle, J N ^di   Suman, V J ^di   Bengtsson, N O ^dj   Emdin, S ^dj   Granstrand, B ^dj   Jonsson, H ^dj   Lythgoe, J P ^dl   Kissin, M ^dm   Erikstein, B ^dn,do   Hannisdal, E ^dn   Jacobsen, A B ^dn,do   Varhaug, J E ^dn   Gundersen, S ^do   Hauer Jensen, M ^do   Host H ^do,eg   Nissen Meyer, R ^do,ei   Mitchell, A K ^dp   Robertson, J F R ^dp   Di Palma, M ^dq   Mathe G ^dq   Misset, J L ^dq   Clark, R M ^dr   Levine, M ^dr   Morimoto, K ^ds   Takatsuka, Y ^dt   Crossley, E ^du   Harris, A ^du   Talbot, D ^du   Taylor, M ^du   Martin, A L ^dv,eu   Di Blasio, B ^dw   Ivanov, V ^dx   Semiglazov, V ^dx   Brockschmidt, J ^dy   Cooper, M R ^dy   Makris, A ^eb   Powles, T J ^eb   Smith, I E ^eb   Browne, L ^ed   Graham, P ^ed   Corcoran, N ^ee   Deshpande, N ^ef   Di Martino, L ^ef   Douglas, P ^eg   Lindtner, A ^eg   Notter, G ^eg   Bryant, A J S ^eh   Ewing, G H ^eh   Firth, L A ^eh   Krushen Kosloski, J L ^eh   Foster, L ^ej   George, W D ^ej,fb   Stewart, H J ^ej   Stroner, P ^ej   Anderson, H ^ek   Malmstrom P ^ek   Moller T R ^ek   Ringberg, A ^ek   Ryden L ^ek   Tengrup, I ^ek   Tennvall Nittby, L ^ek   Arnesson, L G ^el   Dufmats, M ^el   Nordenskjold B ^el   Carpenter, J T ^em   Albain, K ^en   Barlow, W ^en   Crowley, J ^en   Green, S ^en   Livingston, R ^en   Martino, S ^en   Osborne, C K ^en   Ravdin, P M ^en   Murray, N ^eo   Royle, G T ^eo   Simmonds, P D ^eo   Askergren, J ^ep   Backdahl M ^ep   Bergh, J ^ep,fg   Fernstad, R ^ep   Fornander, T ^ep   Frisell, J ^ep   Glas, U ^ep   Idestrom K ^ep   Johansson, U ^ep   Perbeck, L ^ep   Rotstein, S ^ep   Rutqvist, L E ^ep   Sandelin, K ^ep   Singnomklao, T ^ep   Skoog, L ^ep,fq   Somell, A ^ep   Wallgren, A ^ep,fm   Wilking, N ^ep   Maibach, R ^eq,er   Thurlimann B ^eq,er   Holli, K ^es   Rouhento, K ^es   Brenner, H ^et   Hercbergs, A ^et   Yoshimoto, M ^ev   DeBoer, G ^ew   Paterson, A H G ^ew   Fyles, A ^ex   Meakin, J W ^ex   Panzarella, T ^ex   Shan, Y ^ey   Shao, Y F ^ey   Wang, X ^ey   Chen, Z M ^al   Pan, H C ^al   Bahi, J ^ez   Reid, M ^fa   Spittle, M ^fa   Bishop, H ^fb   Bundred, N J ^fb   Forsyth, S ^fb   Pai, V R ^fb,fc   Pinder, S E ^fb   Sestak, I ^fb   Deutsch, G P ^fc   Kwong, D L W ^fc   Senanayake, F ^fc   Bianco, A R ^fd   Carlomagno, C ^fd   De Laurentiis, M ^fd   De Placido, S ^fd   Broglio, K ^fe   Buzdar, A U ^fe   Love, R R ^ff   Garmo, H ^fg   Holmberg, L ^fg   Liljegren, G ^fg   Nilsson, J ^fg   Jones, S E ^fh   Loesch, D M ^fh   Janauer, M ^fi   Gluz, O ^fj   Nitz, U ^fj   Dunn, J A ^fk   Lee, M ^fk   Morrison, J M ^fk   Poole, C ^fk   Litton, A ^fl   Karlsson, P ^fm   Chlebowski, R T ^fn   Caffier, H ^fo   more..

^a ACETBC ^*

^b ACETBC   (Japan)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

^d Anglo Celtic Cooperative Oncology Group   (United Kingdom)

^e ARCOSEIN Group   (France)

^f ATLAS Trial Collaborative Study Group   (United Kingdom)

^g Auckland Breast Cancer Study Group   (New Zealand)

^h Australian New Zealand Breast Cancer Trials Group   (Australia)

ⁱ Austrian Breast Cancer Study Group   (Austria)

^j BEATSON WEST OF SCOTLAND CANCER CENTRE   (United Kingdom)

^k Belgian Adjuvant Breast Cancer Project   (Belgium)

^l Berlin Brandenburgische Akademie der Wissenschaften   (Germany)

^m Birmingham General Hospital   (United Kingdom)

ⁿ INSTITUT BERGONIÉ   (France)

^o Institut Bordet   (Belgium)

^p JULES BORDET INSTITUTE   (Belgium)

^q Breast Cancer International Research Group (BCIRG)   (Canada)

^r Maastricht UMC+ Comprehensive Cancer Centre   (Netherlands)

^s British Association of Surgical Oncology BASO II Trialists   (United Kingdom)

^t BRITISH COLUMBIA CANCER AGENCY   (Canada)

^u Cancer and Leukemia Group B   (United States)

^v CANCER CARE ONTARIO   (Canada)

^w INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^x IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^y Cardiff Trialists Group   (United Kingdom)

^z CASE WESTERN RESERVE UNIVERSITY   (United States)

^aa Central Oncology Group   (United States)

^ab CENTRE LÉON BÉRARD   (France)

^ac CENTRE VAL D AURELLE   (France)

^ad François Baclesse Institute   (France)

^ae CENTRE RENÉ HUGUENIN   (France)

^af Centro Oncologico   (Italy)

^ag CHARLES UNIVERSITY   (Czech Republic)

^ah CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^ai Chemo N0 Trial Group   (United Kingdom)

^aj UNIVERSITY OF CHICAGO   (United States)

^ak CHRISTIE HOSPITAL   (United Kingdom)

^al CLINICAL TRIAL SERVICE UNIT   (United Kingdom)

^am Instituto Portugues de Oncologia Francisco Gentil Centro Regional de Oncologia de Coimbra SA   (Portugal)

^an Back Center of Copenhagen   (Denmark)

^ao DANA FARBER CANCER INSTITUTE   (United States)

^ap Danish Breast Cancer Cooperative Group   (Denmark)

^aq Danish Cancer Registry   (Denmark)

^ar HEINRICH HEINE UNIVERSITY   (Germany)

^as Dutch Working Party for Autologous Bone Marrow Transplant in Solid Tumours   (Netherlands)

^at Eastern Cooperative Oncology Group   (United States)

^au Edinburgh Breast Unit   (United Kingdom)

^av Diakonie Klinikum Hamburg   (Germany)

^aw ERASMUS MEDICAL CENTER   (Netherlands)

^ax EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^ay EORTC DATA CENTER   (Belgium)

^az EVANSTON HOSPITAL   (United States)

^ba Finnish Breast Cancer Group   (Finland)

^bb IRCCS   (Italy)

^bc Fondazione Michelangelo   (Italy)

^bd FOX CHASE CANCER CENTER   (United States)

^be French Adjuvant Study Group (GFEA)   (France)

^bf German Adjuvant Breast Group (GABG)   (Germany)

^bg German Breast Cancer Study Group   (Germany)

^bh German Breast Group (GBG Forschungs GmbH)   (Germany)

^bi GHENT UNIVERSITY HOSPITAL   (Belgium)

^bj GIVIO Interdisciplinary Group for Cancer Care Evaluation   (Italy)

^bk VICTORIA INFIRMARY   (United Kingdom)

^bl Gruppo Oncologico Clinico Cooperativo del Nord Est   (Italy)

^bm Gruppo Oncologico Dell'Italia Meridionale (GOIM)   (Italy)

^bn Gruppo Ricerca Ormono Chemio Terapia Adiuvante (GROCTA)   (Italy)

^bo UNIVERSITY OF CAPE TOWN   (South Africa)

^bp Grupo Español de Investigación en Cáncer de Mama GEICAM   (Spain)

^bq HOSPITAL UNIVERSITARIO DE GUADALAJARA   (Mexico)

^br GUNMA UNIVERSITY   (Japan)

^bs GUY S HOSPITAL   (United Kingdom)

^bt UNIVERSITY OF HEIDELBERG   (Germany)

^bu HELIOS KLINIKUM BERLIN BUCH   (Germany)

^bv Hellenic Breast Surgeons Society   (Greece)

^bw Hellenic Cooperative Oncology Group   (Greece)

^bx Hellenic Oncology Research Group   (Greece)

^by Helsinki Deaconess Medical Centre   (Finland)

^bz UNIVERSITY OF HELSINKI   (Finland)

^ca HOSPITAL DEL MAR   (Spain)

^cb UNIVERSITY OF INNSBRUCK   (Austria)

^cc INSTITUT CLAUDIUS REGAUD   (France)

^cd INSTITUT CURIE   (France)

^ce INSTITUT GUSTAVE ROUSSY   (France)

^cf INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^cg UNIVERSITY OF GENOA   (Italy)

^ch ISTITUTO ONCOLOGICO ROMAGNOLO   (Italy)

^ci Integraal Kankercentrum Amsterdam   (Netherlands)

^cj International Breast Cancer Study Group (Ludwig)   (Switzerland)

^ck CHARING CROSS HOSPITAL   (United Kingdom)

^cl INTERNATIONAL DRUG DEVELOPMENT INSTITUTE   (Belgium)

^cm International TABLE Study Group   (Germany)

^cn Israel NSABC   (Israel)

^co NATIONAL CANCER INSTITUTE   (Italy)

^cp Italian Cooperative Chemo Radio Surgical Group   (Italy)

^cq Italian Oncology Group for Clinical Research   (Italy)

^cr Japanese National Hospitals Group Breast Cancer Study Group   (Japan)

^cs Japanese Foundation for Multidisciplinary Treatment of Cancer   (Japan)

^ct KAWASAKI MEDICAL SCHOOL   (Japan)

^cu INSTITUTE OF ONCOLOGY   (Poland)

^cv KUMAMOTO UNIVERSITY   (Japan)

^cw UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^cx UNIVERSITY OF MUNICH   (Germany)

^cy Marseille Laboratoire de Cancerologie Biologique APM   (France)

^cz MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^da METAXA CANCER HOSPITAL   (Greece)

^db Mexican National Medical Centre   (Mexico)

^dc NATIONAL CANCER INSTITUTE   (United States)

^dd NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^de Queen's Cancer Research Institute   (Canada)

^df NATIONAL KYUSHU CANCER CENTER   (Japan)

^dg NSABP Foundation Inc   (United States)

^dh Nolvadex Adjuvant Trial Organisation   (United Kingdom)

^di North Central Cancer Treatment Group Rochester   (United States)

^dj North Sweden Breast Cancer Group   (Sweden)

^dk North West Oncology Group (GONO)   (Italy)

^dl North Western British Surgeons   (United Kingdom)

^dm NORTHWICK PARK HOSPITAL   (United Kingdom)

^dn Norwegian Breast Cancer Group   (Norway)

^do OSLO UNIVERSITY HOSPITAL   (Norway)

^dp NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^dq Oncofrance   (France)

^dr MCMASTER UNIVERSITY   (Canada)

^ds Osaka Prefecture University   (Japan)

^dt OSAKA NATIONAL HOSPITAL   (Japan)

^du CHURCHILL HOSPITAL   (United Kingdom)

^dv PACS Adjuvant Study Group   (France)

^dw Parma Hospital   (Italy)

^dx N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^dy Piedmont Oncology Association   (United States)

^dz OITA PREFECTURAL HOSPITAL   (Japan)

^ea UNIVERSITY OF PRETORIA   (South Africa)

^eb ROYAL MARSDEN HOSPITAL   (United Kingdom)

^ec ST GEORGE S HOSPITAL   (United Kingdom)

^ed ST GEORGE HOSPITAL   (Australia)

^ee ST LUKE S HOSPITAL   (Ireland)

^ef Sardinia Oncology Hospital A Businico   (Italy)

^eg SASIB International Trialists   (South Africa)

^eh SASKATCHEWAN CANCER AGENCY   (Canada)

^ei Scandinavian Adjuvant Chemotherapy Study Group   (Norway)

^ej Scottish Cancer Therapy Network   (United Kingdom)

^ek South Swedish Breast Cancer Group   (Sweden)

^el South East Sweden Breast Cancer Group   (Sweden)

^em Southeastern Cancer Study Group and Alabama Breast Cancer Project   (United States)

^en Southwest Oncology Group   (United States)

^eo Southampton Oceanography Cent   (United Kingdom)

^ep Stockholm Breast Cancer Study Group   (Sweden)

^eq SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

^er OSAKO   (Switzerland)

^es TAMPERE UNIVERSITY HOSPITAL   (Finland)

^et TEL AVIV UNIVERSITY   (Israel)

^eu High Dose Chemotherapy for Breast Cancer Study Group (PEGASE)   (France)

^ev CANCER INSTITUTE HOSPITAL   (Japan)

^ew Toronto Edmonton Breast Cancer Study Group   (Canada)

^ex PRINCESS MARGARET HOSPITAL   (Canada)

^ey CAPITAL MEDICAL UNIVERSITY   (China)

^ez SALAH AZAIEZ INSTITUTE   (Tunisia)

^fa UK Multicentre Cancer Chemotherapy Study Group   (United Kingdom)

^fb UK ANZ DCIS Trial in Women with Locally Excised DCIS   (United Kingdom)

^fc UK/Asia Collaborative Breast Cancer Group   (United Kingdom)

^fd UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^fe UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^ff UNIVERSITY OF WISCONSIN   (United States)

^fg Uppsala Örebro Breast Cancer Study Group   (Sweden)

^fh Developmental Therapeutics Committee and Co Chair of the Genitourinary Committee   (United States)

^fi UNIVERSITY OF VIENNA   (Austria)

^fj West German Study Group (WSG)   (Germany)

^fk West Midlands Oncology Association   (United Kingdom)

^fl West of Scotland Breast Trial Group   (United Kingdom)

^fm West Swedish Breast Cancer Study Group   (Sweden)

^fn Western Cancer Study Group   (United States)

^fo UNIVERSITY OF WÜRZBURG   (Germany)

^fp UNIVERSITY OF AMSTERDAM   (Netherlands)

^fq ALBERT EINSTEIN MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST SURGERY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER INVASION; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CAUSE OF DEATH; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MASTITIS; MULTIPLE CANCER; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TUMOR NECROSIS; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; BREAST TUMOR; META ANALYSIS (TOPIC); MIDDLE AGED; MULTICENTER STUDY (TOPIC); MULTIMODALITY CANCER THERAPY; PAGET NIPPLE DISEASE; REVIEW; SECOND CANCER; SEGMENTAL MASTECTOMY; STATISTICS; TUMOR RECURRENCE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; META-ANALYSIS AS TOPIC; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; RADIOTHERAPY, ADJUVANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TAMOXIFEN;

EID: 78650717087     PISSN: 10526773     EISSN: 17456614     Source Type: Book Series    
DOI: 10.1093/jncimonographs/lgq039     Document Type: Article

References (17)

1. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687-1717.
2. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087-2106.
3. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328(22):1581-1586.
4. Fisher B, Dignam J, Wolmark N, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998;16(2):441-452.
5. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) eight-year update of Protocol B-17. Intraductal carcinoma. Cancer. 1999;86(3):429-438.
6. Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet. 2000;355(9203):528-533.
7. Bijker N, Peterse JL, Duchateau L, et al. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer. 2001;84(4):539-544.
8. Bijker N, Peterse JL, Duchateau L, et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol. 2001;19(8):2263-2271.
9. Bijker N, Meijnen P, Peterse JL, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol. 2006;24(21):3381-3387.
10. Emdin SO, Granstrand B, Ringberg A, et al. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol. 2006;45(5):536-543.
11. Ringberg A, Nordgren H, Thorstensson S, et al. Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast-results from the Swedish randomised trial. Eur J Cancer. 2007;43(2):291-298.
12. Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol. 2008;26(8):1247-1252.
13. Houghton J, George WD, Cuzick J, Duggan C, Fentiman IS, Spittle M. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet. 2003;362(9378):95-102.
14. Solin LJ, Fourquet A, Vicini FA, et al. Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast. Cancer. 2005;103(6):1137-1146.
15. Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006;24(7):1031-1036.
16. Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27(32):5319-5324.
17. Silverstein MJ, Lagios MD, Groshen S, et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 1999;340(19):1455-1461.